Demonstration of 2-hydroxybenzoylglycine as a drug binding inhibitor in newborn infants

about

In vitro displacement of bilirubin by antibiotics and 2-hydroxybenzoylglycine in newborns

P2860

Q35564504-3D908E82-7B1D-48A6-BCE3-E219911EAA94

P2860

Demonstration of 2-hydroxybenzoylglycine as a drug binding inhibitor in newborn infants

Item

http://www.wikidata.org/entity/Q35580401

description

1987 nî lūn-bûn

@nan

1987年の論文

@ja

1987年論文

@yue

1987年論文

@zh-hant

1987年論文

@zh-hk

1987年論文

@zh-mo

1987年論文

@zh-tw

1987年论文

@wuu

1987年论文

@zh

1987年论文

@zh-cn

name

Demonstration of 2-hydroxybenzoylglycine as a drug binding inhibitor in newborn infants

@ast

Demonstration of 2-hydroxybenzoylglycine as a drug binding inhibitor in newborn infants

@en

type

Item

label

Demonstration of 2-hydroxybenzoylglycine as a drug binding inhibitor in newborn infants

@ast

Demonstration of 2-hydroxybenzoylglycine as a drug binding inhibitor in newborn infants

@en

prefLabel

Demonstration of 2-hydroxybenzoylglycine as a drug binding inhibitor in newborn infants

@ast

Demonstration of 2-hydroxybenzoylglycine as a drug binding inhibitor in newborn infants

@en

P1476

Demonstration of 2-hydroxybenzoylglycine as a drug binding inhibitor in newborn infants

@en

P2093

B Suh

http://www.w3.org/2001/XMLSchema#string

D M Lichtenwalner

http://www.w3.org/2001/XMLSchema#string

S J Wadsworth

http://www.w3.org/2001/XMLSchema#string

P2860

Altered plasma albumin in the newborn infant

Isolation and chemical characterization of 2-hydroxybenzoylglycine as a drug binding inhibitor in uremia

New rapid assay for nafcillin in serum by spectrofluorometry.

Partial purification and characterization of the drug-binding-defect inducer in uremia.

Allergy to methyl salicylate.

Recognition of food additives as a cause of symptoms of allergy.

Clinical pharmacology of the new penicillins. 1. The importance of serum protein binding in determining antimicrobial activity and concentration in serum.

Protein binding of diphenylhydantoin and desmethylimipramine in plasma from patients with poor renal function.

Influence of binding on the toxicity of bilirubin.

Drug-protein binding in the newborn infant.

P304

1125-1131

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI113169

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

1987-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

3654972

http://www.w3.org/2001/XMLSchema#string

P932

442355

http://www.w3.org/2001/XMLSchema#string

Demonstration of 2-hydroxybenzoylglycine as a drug binding inhibitor in newborn infants

about

P2860

P2860

Demonstration of 2-hydroxybenzoylglycine as a drug binding inhibitor in newborn infants

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932